CF PharmTech, Inc. (02652) disclosed that on 24 February 2026, the company repurchased 27,000 shares at prices ranging from HKD 36.60 to HKD 37.18, with a total payment of HKD 997,440. These repurchased shares will be held as treasury shares, bringing the total number of treasury shares to 0.39 million.

Following this transaction, the number of shares excluding treasury shares stands at 301.83 million, while the overall issued share count remains at 302.22 million. The repurchase forms part of an authorized mandate to buy back up to 30.22 million shares, with 0.39 million shares repurchased to date. A moratorium imposed on new share issuance or treasury share transactions is in place until 26 March 2026.